G Medical Innovations Holdings Ltd
GMVDF
$0.0002
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 4.42M | 4.34M | 4.26M | 4.61M | 4.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.42M | 4.34M | 4.26M | 4.61M | 4.96M |
| Cost of Revenue | 3.64M | 6.22M | 8.81M | 6.13M | 3.45M |
| Gross Profit | 784.00K | -1.88M | -4.55M | -1.52M | 1.51M |
| SG&A Expenses | 25.90M | 23.29M | 20.69M | 15.74M | 10.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.83M | 31.79M | 31.74M | 23.84M | 15.93M |
| Operating Income | -27.41M | -27.45M | -27.48M | -19.23M | -10.97M |
| Income Before Tax | -13.94M | -18.52M | -23.09M | -18.84M | -14.59M |
| Income Tax Expenses | 16.00K | 15.50K | 15.00K | 6.00K | -3.00K |
| Earnings from Continuing Operations | -13.96 | -18.53 | -23.10 | -18.85 | -14.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 437.00K | 378.00K | 319.00K | 224.50K | 130.00K |
| Net Income | -13.52M | -18.15M | -22.78M | -18.62M | -14.46M |
| EBIT | -27.41M | -27.45M | -27.48M | -19.23M | -10.97M |
| EBITDA | -26.65M | -26.59M | -26.52M | -18.22M | -9.93M |
| EPS Basic | -25.85 | -38.25 | -50.65 | -46.90 | -43.15 |
| Normalized Basic EPS | -15.88 | -23.63 | -31.39 | -29.10 | -26.81 |
| EPS Diluted | -25.85 | -38.25 | -50.65 | -46.90 | -43.15 |
| Normalized Diluted EPS | -15.88 | -23.63 | -31.39 | -29.10 | -26.81 |
| Average Basic Shares Outstanding | 2.88M | 2.34M | 1.80M | 1.55M | 1.30M |
| Average Diluted Shares Outstanding | 2.88M | 2.34M | 1.80M | 1.55M | 1.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
